Indivior Pharmaceuticals, Inc. INDV SUBLOCADE — Inventory write-downs and other
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryWriteDown.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's sublocade — inventory write-downs and other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's SUBLOCADE — inventory write-downs and other?
- Indivior Pharmaceuticals, Inc. (INDV) reported SUBLOCADE — inventory write-downs and other of $2.5M in Q4 2025.
- What does SUBLOCADE — inventory write-downs and other mean?
- This metric captures the financial impact of inventory adjustments, including write-downs for obsolescence, damage, or expiration related to a specific product line. It reflects the efficiency of supply chain management and the accuracy of demand forecasting for the product. High or increasing values may indicate potential issues with product shelf-life, market demand volatility, or inefficient inventory turnover.